AC8 Moving Forward - 2024, page-30

After suspension Cylon.

Like i said before Neuvis isn't dead - it actually works but the market doesn't want it...the previous management delivered a product that met spec and works but at the moment there isn't the demand for it so its extremely expensive to do in small batches which makes it uncommercial, therefore there wasn't much point spending additional money on it going forward when the fundamental market for it, wasn't there. Cannpal is a similar story and this is why the board at the time elected to send it private, but maintain a carry ownership. They understood the market was not interested in the animal health side of the ledger in this sector and decided not to spend additional funds on it for no return. If CannPal is successful which I think it will be, AC8 will have a stake in it of circa 49%.